{"transactions":[{"id":731907,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2026-06-18T20:05:04.000Z","date":"2026-06-17","kind":"sale","planned":false,"acquired":false,"shares":29,"price":23.25,"value":674.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":14560,"source":{"system":"sec-edgar","filing":"0001193125-26-275804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526275804/ownership.xml","form_type":"4"}},{"id":748293,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:11:22.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026."}],"balance_after":42688,"source":{"system":"sec-edgar","filing":"0001193125-26-259927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000119312526259927/ownership.xml","form_type":"4"}},{"id":747789,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2026-06-05T21:10:47.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 3,332 fewer shares included in in Column 5 on reporting person's prior Form 4s due to an administrative error."}],"balance_after":48145,"source":{"system":"sec-edgar","filing":"0001193125-26-259924","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259924/ownership.xml","form_type":"4"}},{"id":747788,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T21:00:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259855/ownership.xml","form_type":"4"}},{"id":747825,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:50:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000119312526259822/ownership.xml","form_type":"4"}},{"id":747787,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:45:03.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259808/ownership.xml","form_type":"4"}},{"id":747786,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40889,"kind":"person","name":"Houghton Michael","position":1,"cik":"0001873008","reported_name":"Houghton Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:40:09.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259776","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259776/ownership.xml","form_type":"4"}},{"id":747785,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:35:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259742","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259742/ownership.xml","form_type":"4"}},{"id":747784,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40887,"kind":"person","name":"ALTIG ANTHONY E","position":1,"cik":"0001215907","reported_name":"ALTIG ANTHONY E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:30:16.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 4, 2027 and (2) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":8000,"derivative":{"exercise_price":24.11,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-259697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259697/ownership.xml","form_type":"4"}},{"id":747783,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2026-06-05T20:25:02.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."}],"balance_after":14589,"source":{"system":"sec-edgar","filing":"0001193125-26-259661","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259661/ownership.xml","form_type":"4"}},{"id":748127,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-05T20:10:02.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026."}],"balance_after":60330,"source":{"system":"sec-edgar","filing":"0001193125-26-259562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000119312526259562/ownership.xml","form_type":"4"}},{"id":748113,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-05T20:05:03.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":50750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increased the number of shares of common stock authorized for issuance under the Plan (the \"Plan Amendment\"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 688 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2026."}],"balance_after":163354,"source":{"system":"sec-edgar","filing":"0001193125-26-259517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000119312526259517/ownership.xml","form_type":"4"}},{"id":309089,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-28T00:55:23.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":471698,"price":26.5,"value":12499997.0,"ownership":{"direct":true},"balance_after":4977089,"source":{"system":"sec-edgar","filing":"0001123292-26-000751","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112329226000751/form4.xml","form_type":"4"}},{"id":824088,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2026-03-31T20:25:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":16,"price":27.49,"value":439.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.39 to $27.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":11089,"source":{"system":"sec-edgar","filing":"0001193125-26-134669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134669/ownership.xml","form_type":"4"}},{"id":824087,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2026-03-31T20:25:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":312,"price":26.6502,"value":8314.8624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.35 to $27.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":11105,"source":{"system":"sec-edgar","filing":"0001193125-26-134669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134669/ownership.xml","form_type":"4"}},{"id":824086,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2026-03-31T20:25:04.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects 300 fewer shares than were included in Column 5 on reporting person's prior Form 4 due to an administrative error."}],"balance_after":11417,"source":{"system":"sec-edgar","filing":"0001193125-26-134669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134669/ownership.xml","form_type":"4"}},{"id":824085,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:20:03.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":9,"price":27.49,"value":247.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.39 to $27.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":37477,"source":{"system":"sec-edgar","filing":"0001193125-26-134645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134645/ownership.xml","form_type":"4"}},{"id":824084,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:20:03.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":188,"price":26.6502,"value":5010.2376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.35 to $27.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":37486,"source":{"system":"sec-edgar","filing":"0001193125-26-134645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134645/ownership.xml","form_type":"4"}},{"id":824083,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:20:03.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."}],"balance_after":37674,"source":{"system":"sec-edgar","filing":"0001193125-26-134645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526134645/ownership.xml","form_type":"4"}},{"id":824331,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:15:06.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2025."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001193125-26-134601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000119312526134601/ownership.xml","form_type":"4"}},{"id":824205,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:10:02.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,909 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2025."}],"balance_after":45642,"source":{"system":"sec-edgar","filing":"0001193125-26-134554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000119312526134554/ownership.xml","form_type":"4"}},{"id":824200,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-31T20:05:09.000Z","date":"2026-03-29","kind":"grant","planned":false,"acquired":true,"shares":94250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\"). The RSUs vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030."},{"field":"shares","element":"transactionShares","label":"F2","text":"RSUs represent 65% of the reporting person's annual equity grant. The remaining 35% of the RSUs granted are contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the \"Plan\") that increases the number of shares of common stock authorized for issuance under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,909 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2025."}],"balance_after":111916,"source":{"system":"sec-edgar","filing":"0001193125-26-134496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000119312526134496/ownership.xml","form_type":"4"}},{"id":318298,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B warrants to purchase Common Stock","published_at":"2025-10-03T20:30:21.000Z","date":"2025-08-08","kind":"purchase","planned":false,"acquired":true,"shares":1147960,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 2,295,920 shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), Class A warrants to purchase 1,147,960 shares of Common Stock (the \"Class A Warrants\"), and Class B warrants to purchase 1,147,960 shares of Common Stock (the \"Class B Warrants\"), at a combined price of $19.60 per share of Common Stock and accompanying one half of one Class A Warrant and one half of one Class B Warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class B Warrants are exercisable at any time after November 15, 2026 and expire on December 31, 2026, provided that the Class B Warrants will automatically terminate in full and be extinguished and will no longer be exercisable in the event that the Issuer publicly announces prior to November 15, 2026 that the Issuer has received at least $75 million in the aggregate of non-dilutive capital in connection with a collaboration agreement. A holder of the Class B Warrants may not exercise the Class B Warrants if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Class B Warrants are exercisable at any time after November 15, 2026 and expire on December 31, 2026, provided that the Class B Warrants will automatically terminate in full and be extinguished and will no longer be exercisable in the event that the Issuer publicly announces prior to November 15, 2026 that the Issuer has received at least $75 million in the aggregate of non-dilutive capital in connection with a collaboration agreement. A holder of the Class B Warrants may not exercise the Class B Warrants if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."}],"balance_after":1147960,"derivative":{"exercise_price":21.6,"exercise_date":"2026-11-15","expiration_date":"2026-12-31","underlying":"Common Stock","underlying_shares":1147960},"source":{"system":"sec-edgar","filing":"0001123292-25-000510","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112329225000510/form4.xml","form_type":"4"}},{"id":318297,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A warrants to purchase Common Stock","published_at":"2025-10-03T20:30:21.000Z","date":"2025-08-08","kind":"purchase","planned":false,"acquired":true,"shares":1147960,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 2,295,920 shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), Class A warrants to purchase 1,147,960 shares of Common Stock (the \"Class A Warrants\"), and Class B warrants to purchase 1,147,960 shares of Common Stock (the \"Class B Warrants\"), at a combined price of $19.60 per share of Common Stock and accompanying one half of one Class A Warrant and one half of one Class B Warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class A Warrants are exercisable at any time after the date of issuance and expire on the earlier of (i) five years from the date of issuance, or August 11, 2030, and (ii) the date that is 30 days after the public announcement that the Issuer has completed enrollment (of at least 200 patients total) for its Phase 2 clinical study evaluating ABI-5366 vs. valacyclovir. A holder of the Class A Warrants may not exercise the Class A Warrants if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class A Warrants are exercisable at any time after the date of issuance and expire on the earlier of (i) five years from the date of issuance, or August 11, 2030, and (ii) the date that is 30 days after the public announcement that the Issuer has completed enrollment (of at least 200 patients total) for its Phase 2 clinical study evaluating ABI-5366 vs. valacyclovir. A holder of the Class A Warrants may not exercise the Class A Warrants if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."}],"balance_after":1147960,"derivative":{"exercise_price":21.6,"underlying":"Common Stock","underlying_shares":1147960},"source":{"system":"sec-edgar","filing":"0001123292-25-000510","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112329225000510/form4.xml","form_type":"4"}},{"id":318296,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:30:21.000Z","date":"2025-08-08","kind":"purchase","planned":false,"acquired":true,"shares":2295920,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 2,295,920 shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), Class A warrants to purchase 1,147,960 shares of Common Stock (the \"Class A Warrants\"), and Class B warrants to purchase 1,147,960 shares of Common Stock (the \"Class B Warrants\"), at a combined price of $19.60 per share of Common Stock and accompanying one half of one Class A Warrant and one half of one Class B Warrant."}],"balance_after":4505391,"source":{"system":"sec-edgar","filing":"0001123292-25-000510","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112329225000510/form4.xml","form_type":"4"}},{"id":1107838,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T20:05:04.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, June 16, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on June 16, 2029."}],"balance_after":600,"derivative":{"exercise_price":17.24,"expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0000950170-25-087346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025087346/ownership.xml","form_type":"4"}},{"id":1107837,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO and PAO"}}],"security":"Common Stock","published_at":"2025-06-17T20:05:04.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: June 16, 2026; June 16, 2027; June 16, 2028; and June 16, 2029."}],"balance_after":5097,"source":{"system":"sec-edgar","filing":"0000950170-25-087346","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025087346/ownership.xml","form_type":"4"}},{"id":1117773,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40889,"kind":"person","name":"Houghton Michael","position":1,"cik":"0001873008","reported_name":"Houghton Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:21.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083704/ownership.xml","form_type":"4"}},{"id":1117802,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:19.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000095017025083703/ownership.xml","form_type":"4"}},{"id":1117771,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083702/ownership.xml","form_type":"4"}},{"id":1117772,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:14.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083700/ownership.xml","form_type":"4"}},{"id":1117770,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16993,"kind":"person","name":"RINGO WILLIAM R","position":1,"cik":"0001238325","reported_name":"RINGO WILLIAM R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:11.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083695/ownership.xml","form_type":"4"}},{"id":1117769,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40887,"kind":"person","name":"ALTIG ANTHONY E","position":1,"cik":"0001215907","reported_name":"ALTIG ANTHONY E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083694/ownership.xml","form_type":"4"}},{"id":1117768,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":3500,"derivative":{"exercise_price":15.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-083693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083693/ownership.xml","form_type":"4"}},{"id":1171725,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-15T21:30:04.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":757,"price":9.8481,"value":7455.0117,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":18347,"source":{"system":"sec-edgar","filing":"0000950170-25-054331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025054331/ownership.xml","form_type":"4"}},{"id":1186552,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:11.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2036."}],"balance_after":25500,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0000950170-25-048488","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000095017025048488/ownership.xml","form_type":"4"}},{"id":1186337,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:10.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029."}],"balance_after":1900,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0000950170-25-048487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025048487/ownership.xml","form_type":"4"}},{"id":1186336,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:05:10.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":180,"price":9.8481,"value":1772.658,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":4617,"source":{"system":"sec-edgar","filing":"0000950170-25-048487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025048487/ownership.xml","form_type":"4"}},{"id":1186335,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:05:10.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":1655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2026; March 29, 2027; March 29, 2028; and March 29, 2029."}],"balance_after":4797,"source":{"system":"sec-edgar","filing":"0000950170-25-048487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025048487/ownership.xml","form_type":"4"}},{"id":1186542,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:07.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":71100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029."}],"balance_after":71100,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":71100},"source":{"system":"sec-edgar","filing":"0000950170-25-048486","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017025048486/ownership.xml","form_type":"4"}},{"id":1186541,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-04-01T20:05:07.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":355,"price":9.8481,"value":3496.0755,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 208 shares acquired under the Assembly Biosciences, Inc. Second Amended and Restated 2018 Employee Stock Purchase Plan on November 14 14, 2024."}],"balance_after":14757,"source":{"system":"sec-edgar","filing":"0000950170-25-048486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017025048486/ownership.xml","form_type":"4"}},{"id":1186334,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:06.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029."}],"balance_after":20400,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0000950170-25-048485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025048485/ownership.xml","form_type":"4"}},{"id":1186333,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:05:06.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":197,"price":9.8481,"value":1940.0757,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.56 to $10.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":11674,"source":{"system":"sec-edgar","filing":"0000950170-25-048485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025048485/ownership.xml","form_type":"4"}},{"id":1186679,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-01T20:05:03.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029."}],"balance_after":24200,"derivative":{"exercise_price":10.62,"expiration_date":"2035-03-29","underlying":"Common Stock","underlying_shares":24200},"source":{"system":"sec-edgar","filing":"0000950170-25-048483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000095017025048483/ownership.xml","form_type":"4"}},{"id":1319783,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40889,"kind":"person","name":"Houghton Michael","position":1,"cik":"0001873008","reported_name":"Houghton Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-31T21:24:14.000Z","date":"2024-12-30","kind":"purchase","planned":false,"acquired":true,"shares":3202,"price":15.6145,"value":49997.629,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.54 to $15.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within."}],"balance_after":3202,"source":{"system":"sec-edgar","filing":"0000950170-24-141616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024141616/ownership.xml","form_type":"4"}},{"id":328011,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-24T01:26:39.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":true,"shares":940499,"price":21.37,"value":20098463.63,"ownership":{"direct":true},"balance_after":2209471,"source":{"system":"sec-edgar","filing":"0000904454-24-000669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000090445424000669/ownership.xml","form_type":"4"}},{"id":1350820,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-26T14:15:02.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":14.85,"value":74250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is the midpoint at which the shares were purchased. 5,000 shares were purchased on November 25, 2024, in multiple transactions at prices ranging from $14.75 to 14.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":728113,"source":{"system":"sec-edgar","filing":"0001079973-24-001637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001637/ownership.xml","form_type":"4"}},{"id":1350819,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-26T14:15:02.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":2976,"price":15,"value":44640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 represent shares purchased by the reporting person on November 25, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"2,976 shares were purchased on November 25, 2024 at $15.00."}],"balance_after":723113,"source":{"system":"sec-edgar","filing":"0001079973-24-001637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001637/ownership.xml","form_type":"4"}},{"id":1350818,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-26T14:15:02.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":17024,"price":14.8675,"value":253104.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person on November 22, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the midpoint at which the shares were purchased. 17,024 shares were purchased on November 22, 2024, in multiple transactions at prices ranging from $14.735 to $15.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":720137,"source":{"system":"sec-edgar","filing":"0001079973-24-001637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001637/ownership.xml","form_type":"4"}},{"id":1358843,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-11-19T21:05:03.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":40,"price":16.29,"value":651.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":11871,"source":{"system":"sec-edgar","filing":"0000950170-24-128557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024128557/ownership.xml","form_type":"4"}},{"id":1388559,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-09T13:15:03.000Z","date":"2024-10-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":14.58,"value":145800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person on October 8, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average at which the shares were purchased. 10,000 shares were purchased on October 8, 2024, in multiple transactions at prices ranging from $14.29 to 14.64. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":703113,"source":{"system":"sec-edgar","filing":"0001079973-24-001375","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001375/ownership.xml","form_type":"4"}},{"id":1390719,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:05:07.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":157,"price":14.81,"value":2325.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":11911,"source":{"system":"sec-edgar","filing":"0000950170-24-112897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024112897/ownership.xml","form_type":"4"}},{"id":1390819,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-10-04T20:05:03.000Z","date":"2024-10-03","kind":"sale","planned":false,"acquired":false,"shares":197,"price":14.81,"value":2917.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":14904,"source":{"system":"sec-edgar","filing":"0000950170-24-112896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024112896/ownership.xml","form_type":"4"}},{"id":1440586,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-08-05T20:10:03.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":785,"price":14.2325,"value":11172.5125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":12068,"source":{"system":"sec-edgar","filing":"0000950170-24-090743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024090743/ownership.xml","form_type":"4"}},{"id":1440931,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-05T20:05:15.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":981,"price":14.2325,"value":13962.0825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":15101,"source":{"system":"sec-edgar","filing":"0000950170-24-090724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024090724/ownership.xml","form_type":"4"}},{"id":1458248,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T14:48:47.000Z","date":"2024-07-05","kind":"purchase","planned":false,"acquired":true,"shares":4438,"price":12.52,"value":55563.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is the midpoint of the price range at which the shares were purchased. 4,438 shares were purchased on July 5, 2024, in multiple transactions ranging from $12.40 to $12.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":693113,"source":{"system":"sec-edgar","filing":"0001079973-24-001035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001035/ownership.xml","form_type":"4"}},{"id":1458247,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T14:48:47.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":4562,"price":12.29,"value":56066.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from July 3, 2024, and July 5, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the midpoint of the price range at which the shares were purchased. 4,562 shares were purchased on July 3, 2024, in multiple transactions at prices ranging from $11.99 to $12.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":688675,"source":{"system":"sec-edgar","filing":"0001079973-24-001035","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324001035/ownership.xml","form_type":"4"}},{"id":332662,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase Common Stock","published_at":"2024-06-21T00:31:31.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":179500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), and a warrant to purchase 179,500 shares of Common Stock (the \"Warrant\") at a combined price of $15.46 per share of Common Stock and accompanying warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise."}],"balance_after":179500,"derivative":{"exercise_price":17,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":179500},"source":{"system":"sec-edgar","filing":"0000904454-24-000391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000090445424000391/ownership.xml","form_type":"4"}},{"id":332661,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD","position":1,"cik":"0000882095","reported_name":"GILEAD SCIENCES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T00:31:31.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":179500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), and a warrant to purchase 179,500 shares of Common Stock (the \"Warrant\") at a combined price of $15.46 per share of Common Stock and accompanying warrant."}],"balance_after":1268972,"source":{"system":"sec-edgar","filing":"0000904454-24-000391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000090445424000391/ownership.xml","form_type":"4"}},{"id":1497761,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40890,"kind":"person","name":"Johnson-Pratt Lisa","position":1,"cik":"0001849760","reported_name":"Johnson-Pratt Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:15:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066606/ownership.xml","form_type":"4"}},{"id":1497760,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:15:04.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066605/ownership.xml","form_type":"4"}},{"id":1497767,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":12043,"kind":"person","name":"Mahony Susan","position":1,"cik":"0001463321","reported_name":"Mahony Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:15:03.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463321/000095017024066604/ownership.xml","form_type":"4"}},{"id":1497758,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40889,"kind":"person","name":"Houghton Michael","position":1,"cik":"0001873008","reported_name":"Houghton Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:10:05.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066585/ownership.xml","form_type":"4"}},{"id":1497759,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40888,"kind":"person","name":"Consylman Gina","position":1,"cik":"0001546358","reported_name":"Consylman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:10:03.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066584/ownership.xml","form_type":"4"}},{"id":1497757,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40887,"kind":"person","name":"ALTIG ANTHONY E","position":1,"cik":"0001215907","reported_name":"ALTIG ANTHONY E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:05:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066562/ownership.xml","form_type":"4"}},{"id":1497756,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16993,"kind":"person","name":"RINGO WILLIAM R","position":1,"cik":"0001238325","reported_name":"RINGO WILLIAM R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T20:05:05.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 29, 2025 and (2) the date of the Issuer's 2025 annual meeting of stockholders."}],"balance_after":2750,"derivative":{"exercise_price":15.06,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000950170-24-066560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024066560/ownership.xml","form_type":"4"}},{"id":1501827,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-05-24T20:10:26.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":24,"price":14.9338,"value":358.4112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":3142,"source":{"system":"sec-edgar","filing":"0000950170-24-064589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024064589/ownership.xml","form_type":"4"}},{"id":1501824,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:10:10.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":2117,"price":14.9338,"value":31614.8546,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":19104,"source":{"system":"sec-edgar","filing":"0000950170-24-064586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024064586/ownership.xml","form_type":"4"}},{"id":1501826,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-05-24T20:05:14.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":172,"price":14.9338,"value":2568.6136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":12853,"source":{"system":"sec-edgar","filing":"0000950170-24-064551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024064551/ownership.xml","form_type":"4"}},{"id":1502149,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-05-24T20:05:10.000Z","date":"2024-05-23","kind":"sale","planned":false,"acquired":false,"shares":549,"price":14.9338,"value":8198.6562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.74 to $15.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 208 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on May 14, 2024."}],"balance_after":16082,"source":{"system":"sec-edgar","filing":"0000950170-24-064552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024064552/ownership.xml","form_type":"4"}},{"id":1531894,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-05-01T20:10:06.000Z","date":"2024-04-30","kind":"sale","planned":false,"acquired":false,"shares":1255,"price":12.7068,"value":15947.034,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":13025,"source":{"system":"sec-edgar","filing":"0000950170-24-051271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024051271/ownership.xml","form_type":"4"}},{"id":1531893,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-05-01T20:10:06.000Z","date":"2024-04-29","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved."}],"balance_after":14280,"source":{"system":"sec-edgar","filing":"0000950170-24-051271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024051271/ownership.xml","form_type":"4"}},{"id":1532065,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-05-01T20:05:11.000Z","date":"2024-04-30","kind":"sale","planned":false,"acquired":false,"shares":1569,"price":12.7068,"value":19936.9692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":16423,"source":{"system":"sec-edgar","filing":"0000950170-24-051244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024051244/ownership.xml","form_type":"4"}},{"id":1532064,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-05-01T20:05:11.000Z","date":"2024-04-29","kind":"grant","planned":false,"acquired":true,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved."}],"balance_after":17992,"source":{"system":"sec-edgar","filing":"0000950170-24-051244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024051244/ownership.xml","form_type":"4"}},{"id":1532067,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-05-01T20:05:08.000Z","date":"2024-04-29","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":16109,"source":{"system":"sec-edgar","filing":"0000950170-24-051243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000095017024051243/ownership.xml","form_type":"4"}},{"id":1553306,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":16027,"kind":"person","name":"McHutchison John G","position":1,"cik":"0001738125","reported_name":"McHutchison John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:25:20.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":1206,"price":13.0719,"value":15764.7114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":21221,"source":{"system":"sec-edgar","filing":"0000950170-24-040205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040205/ownership.xml","form_type":"4"}},{"id":1553309,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:20:16.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028."}],"balance_after":1550,"derivative":{"exercise_price":13.3,"expiration_date":"2034-03-29","underlying":"Common Stock","underlying_shares":1550},"source":{"system":"sec-edgar","filing":"0000950170-24-040180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040180/ownership.xml","form_type":"4"}},{"id":1553308,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-02T20:20:16.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":114,"price":13.0719,"value":1490.1966,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":3166,"source":{"system":"sec-edgar","filing":"0000950170-24-040180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040180/ownership.xml","form_type":"4"}},{"id":1553307,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2024-04-02T20:20:16.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2025; March 29, 2026; March 29, 2027; and March 29, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":3280,"source":{"system":"sec-edgar","filing":"0000950170-24-040180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040180/ownership.xml","form_type":"4"}},{"id":1553305,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:15:07.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028."}],"balance_after":17500,"derivative":{"exercise_price":13.3,"expiration_date":"2034-03-29","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-24-040162","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040162/ownership.xml","form_type":"4"}},{"id":1553304,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2024-04-02T20:15:07.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":197,"price":13.0719,"value":2575.1643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":10947,"source":{"system":"sec-edgar","filing":"0000950170-24-040162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017024040162/ownership.xml","form_type":"4"}},{"id":1553827,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:10:08.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028."}],"balance_after":20000,"derivative":{"exercise_price":13.3,"expiration_date":"2034-03-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-040149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000095017024040149/ownership.xml","form_type":"4"}},{"id":1553809,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:05:06.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2025; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2028."}],"balance_after":65000,"derivative":{"exercise_price":13.3,"expiration_date":"2034-03-29","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000950170-24-040132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024040132/ownership.xml","form_type":"4"}},{"id":1553808,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-02T20:05:06.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":354,"price":13.0719,"value":4627.4526,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":13826,"source":{"system":"sec-edgar","filing":"0000950170-24-040132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024040132/ownership.xml","form_type":"4"}},{"id":1557609,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-29T20:05:11.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":392,"price":12.87,"value":5045.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects equitable adjustment of the number of shares of common stock beneficially owned by the reporting person as a result of a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2024, which is exempt from reporting pursuant to Rule 16a-9."}],"balance_after":14180,"source":{"system":"sec-edgar","filing":"0000950170-24-038630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000095017024038630/ownership.xml","form_type":"4"}},{"id":1675120,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T16:01:21.000Z","date":"2024-01-18","kind":"purchase","planned":false,"acquired":true,"shares":345086,"price":0.8,"value":276068.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"345,086 shares were purchased on January 18, 2024, in multiple transactions at $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":8209372,"source":{"system":"sec-edgar","filing":"0001079973-24-000085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324000085/ownership.xml","form_type":"4"}},{"id":1675119,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T16:01:21.000Z","date":"2024-01-17","kind":"purchase","planned":false,"acquired":true,"shares":299994,"price":0.784,"value":235195.296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from January 17, 2024, to January 18, 2024, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the midpoint of the price range at which the shares were purchased. 299,994 shares were purchased on January 17, 2024, in multiple transactions at prices ranging from $0.768 to $0.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":7864286,"source":{"system":"sec-edgar","filing":"0001079973-24-000085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997324000085/ownership.xml","form_type":"4"}},{"id":1731040,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:10:27.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.667,"value":66700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 100,000 shares purchased on November 21, 2023, were bought in transactions at prices ranging from $0.6666 to $0.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":7564292,"source":{"system":"sec-edgar","filing":"0001079973-23-001645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997323001645/ownership.xml","form_type":"4"}},{"id":1731039,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70963,"kind":"person","name":"Schornstein Alexander","position":1,"cik":"0001999256","reported_name":"Schornstein Alexander","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:10:27.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":300000,"price":0.718,"value":215400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased on November 20, 2023, in multiple transactions at prices ranging from $0.695 to $0.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":7464292,"source":{"system":"sec-edgar","filing":"0001079973-23-001645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000107997323001645/ownership.xml","form_type":"4"}},{"id":1732497,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2023-11-21T21:05:30.000Z","date":"2023-11-17","kind":"sale","planned":false,"acquired":false,"shares":477,"price":0.689,"value":328.653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":93774,"source":{"system":"sec-edgar","filing":"0001209191-23-056212","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123056212/doc4.xml","form_type":"4"}},{"id":1744309,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":41009,"kind":"person","name":"Gaggar Anuj","position":1,"cik":"0001999576","reported_name":"Gaggar Anuj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (right to buy)","published_at":"2023-11-13T21:10:21.000Z","date":"2023-11-08","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, November 8, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on November 8, 2027."}],"balance_after":500000,"derivative":{"exercise_price":0.85,"expiration_date":"2033-11-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-054973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999576/000120919123054973/doc4.xml","form_type":"4"}},{"id":1765169,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:15:17.000Z","date":"2023-10-03","kind":"sale","planned":false,"acquired":false,"shares":1891,"price":0.7953,"value":1503.9123,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":94251,"source":{"system":"sec-edgar","filing":"0001209191-23-051934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123051934/doc4.xml","form_type":"4"}},{"id":1765168,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40891,"kind":"person","name":"White Nicole S","position":1,"cik":"0001993254","reported_name":"White Nicole S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Manufacturing Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:15:17.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024."}],"balance_after":96142,"source":{"system":"sec-edgar","filing":"0001209191-23-051934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123051934/doc4.xml","form_type":"4"}},{"id":1765438,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:10:13.000Z","date":"2023-10-03","kind":"sale","planned":false,"acquired":false,"shares":1891,"price":0.7953,"value":1503.9123,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":150853,"source":{"system":"sec-edgar","filing":"0001209191-23-051910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000120919123051910/doc4.xml","form_type":"4"}},{"id":1765437,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:10:13.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024."}],"balance_after":152744,"source":{"system":"sec-edgar","filing":"0001209191-23-051910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000120919123051910/doc4.xml","form_type":"4"}},{"id":1765428,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-10-04T20:05:17.000Z","date":"2023-10-03","kind":"sale","planned":false,"acquired":false,"shares":2363,"price":0.7953,"value":1879.2939,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":174923,"source":{"system":"sec-edgar","filing":"0001209191-23-051888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000120919123051888/doc4.xml","form_type":"4"}},{"id":1765427,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-10-04T20:05:17.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On October 2, 2023, a performance-based vesting condition was achieved. These shares of common stock vest in two equal installments, assuming continuous service on each vesting date, as follows: October 2, 2023 and October 2, 2024."}],"balance_after":177286,"source":{"system":"sec-edgar","filing":"0001209191-23-051888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000120919123051888/doc4.xml","form_type":"4"}},{"id":1816552,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40966,"kind":"person","name":"Delaney William E IV","position":1,"cik":"0001812734","reported_name":"Delaney William E IV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-08-03T20:10:09.000Z","date":"2023-08-02","kind":"sale","planned":false,"acquired":false,"shares":9461,"price":1.0879,"value":10292.6219,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0801 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":142744,"source":{"system":"sec-edgar","filing":"0001209191-23-044405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812734/000120919123044405/doc4.xml","form_type":"4"}},{"id":1816535,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":40962,"kind":"person","name":"Okazaki Jason A","position":1,"cik":"0001807214","reported_name":"Okazaki Jason A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-03T20:05:27.000Z","date":"2023-08-02","kind":"sale","planned":false,"acquired":false,"shares":11827,"price":1.0879,"value":12866.5933,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0801 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":164786,"source":{"system":"sec-edgar","filing":"0001209191-23-044397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807214/000120919123044397/doc4.xml","form_type":"4"}},{"id":1823461,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":36779,"kind":"person","name":"Bjorkquist Jeanette M","position":1,"cik":"0001945064","reported_name":"Bjorkquist Jeanette M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2023-07-25T20:30:32.000Z","date":"2023-07-24","kind":"sale","planned":false,"acquired":false,"shares":844,"price":1.0668,"value":900.3792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":26688,"source":{"system":"sec-edgar","filing":"0001209191-23-043309","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919123043309/doc4.xml","form_type":"4"}}],"next_cursor":"2023-07-25T20:30:32.000000Z,1823461"}